Cellebrite/$CLBT
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Cellebrite
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
Ticker
$CLBT
Sector
Primary listing
Industry
Software
Headquarters
Petah Tikva, Israel
Employees
1,167
ISIN
IL0011794802
Website
Cellebrite Metrics
BasicAdvanced
$3.9B
-
-$0.89
1.44
-
Price and volume
Market cap
$3.9B
Beta
1.44
52-week high
$26.30
52-week low
$11.47
Average daily volume
1.6M
Financial strength
Current ratio
1.819
Quick ratio
1.705
Long term debt to equity
1.759
Total debt to equity
2.917
Profitability
EBITDA (TTM)
70.485
Gross margin (TTM)
84.06%
Net profit margin (TTM)
-46.34%
Operating margin (TTM)
14.30%
Effective tax rate (TTM)
-3.69%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
6.05%
Return on equity (TTM)
-115.35%
Valuation
Price to revenue (TTM)
8.544
Price to book
10.65
Price to tangible book (TTM)
11.95
Price to free cash flow (TTM)
27.094
Free cash flow yield (TTM)
3.69%
Free cash flow per share (TTM)
60.20%
Growth
Revenue change (TTM)
22.04%
Earnings per share change (TTM)
50.44%
3-year revenue growth (CAGR)
17.96%
3-year earnings per share growth (CAGR)
8.30%
What the Analysts think about Cellebrite
Analyst ratings (Buy, Hold, Sell) for Cellebrite stock.
Bulls say / Bears say
Cellebrite reported a 27% year-over-year increase in annual recurring revenue (ARR) to $331.8 million and a 26% rise in total revenue to $89.6 million, indicating strong financial performance. (Investing.com)
TD Cowen raised its price target for Cellebrite to $23.00, citing expectations of sustained growth over 20% and a goal of $1 billion in ARR by FY27. (Investing.com)
Cellebrite's stock reached an all-time high of $17.48, reflecting increased investor confidence and market performance. (Investing.com)
Cellebrite's net retention rate has slightly decreased, which could indicate challenges in maintaining existing customer revenue. (Investing.com)
The company's spend on solutions by law enforcement agencies is small relative to their total investigation spend, potentially limiting growth. (Investing.com)
Cellebrite's partnership with Relativity is still in its early stages, and the company is cautious about updating targets before proper execution, indicating potential uncertainties. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.
Cellebrite Financial Performance
Revenues and expenses
Cellebrite Earnings Performance
Company profitability
Cellebrite News
AllArticlesVideos
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
GlobeNewsWire·3 days ago
Cellebrite to Acquire Corellium
GlobeNewsWire·3 weeks ago
Cellebrite Announces Participation in Upcoming Investor Conferences
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cellebrite stock?
Cellebrite (CLBT) has a market cap of $3.9B as of June 27, 2025.
What is the P/E ratio for Cellebrite stock?
The price to earnings (P/E) ratio for Cellebrite (CLBT) stock is 0 as of June 27, 2025.
Does Cellebrite stock pay dividends?
No, Cellebrite (CLBT) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Cellebrite dividend payment date?
Cellebrite (CLBT) stock does not pay dividends to its shareholders.
What is the beta indicator for Cellebrite?
Cellebrite (CLBT) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.